{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "exercise",
      "follow-up",
      "rehabilitation",
      "stroke",
      "walking"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32811378",
  "DateCompleted": {
    "Year": "2020",
    "Month": "10",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "10",
    "Day": "30"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "08",
        "Day": "19"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1161/STROKEAHA.120.029245"
    ],
    "Journal": {
      "ISSN": "1524-4628",
      "JournalIssue": {
        "Volume": "51",
        "Issue": "9",
        "PubDate": {
          "Year": "2020",
          "Month": "Sep"
        }
      },
      "Title": "Stroke",
      "ISOAbbreviation": "Stroke"
    },
    "ArticleTitle": "Higher Doses Improve Walking Recovery During Stroke Inpatient Rehabilitation.",
    "Pagination": {
      "StartPage": "2639",
      "EndPage": "2648",
      "MedlinePgn": "2639-2648"
    },
    "Abstract": {
      "AbstractText": [
        "We investigated the effect of higher therapeutic exercise doses on walking during inpatient rehabilitation, typically commencing 1 to 4 weeks poststroke.",
        "This phase II, blinded-assessor, randomized controlled trial recruited from 6 Canadian inpatient rehabilitation units, between 2014 and 2018. Subjects (n=75; 25/group) were randomized into: control (usual care) physical therapy: typically, 1 hour, 5 days/week; Determining Optimal Post-Stroke Exercise (DOSE1): 1 hour, 5 days/week, more than double the intensity of Control (based on aerobic minutes and walking steps); and DOSE2: 2 hours, 5 days/week, more than quadruple the intensity of Control, each for 4 weeks duration. The primary outcome, walking endurance at completion of the 4-week intervention (post-evaluation), was compared across these groups using linear regression. Secondary outcomes at post-evaluation, and longitudinal outcomes at 6 and 12-month evaluations, were also analyzed.",
        "Both DOSE1 (mean change 61 m [95% CI, 9-113], <i>P</i>=0.02) and DOSE2 (mean change 58 m, 6-110, <i>P</i>=0.03) demonstrated greater walking endurance compared with Control at the post-evaluation. Significant improvements were also observed with DOSE2 in gait speed (5-m walk), and both DOSE groups in quality of life (EQ-5D-5 L) compared with Control. Longitudinal analyses revealed that improvements in walking endurance from the DOSE intervention were retained during the 1-year follow-up period over usual care.",
        "This study provides the first preliminary evidence that patients with stroke can improve their walking recovery and quality of life with higher doses of aerobic and stepping activity within a critical time period for neurological recovery. Furthermore, walking endurance benefits achieved from a 4-week intervention are retained over the first-year poststroke. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01915368."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Physical Therapy (T.D.K., T.L.-A., A.S., J.J.E.), University of British Columbia, Vancouver, Canada."
          }
        ],
        "LastName": "Klassen",
        "ForeName": "Tara D",
        "Initials": "TD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Neurosciences, Hotchkiss Brain Institute (S.P.D., M.D.H.)University of Calgary, Canada."
          }
        ],
        "LastName": "Dukelow",
        "ForeName": "Sean P",
        "Initials": "SP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Physical Medicine and Rehabilitation, University of Toronto, Canada (M.T.B.)."
          }
        ],
        "LastName": "Bayley",
        "ForeName": "Mark T",
        "Initials": "MT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Neurology (O.B.), University of British Columbia, Vancouver, Canada."
          }
        ],
        "LastName": "Benavente",
        "ForeName": "Oscar",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Neurosciences, Hotchkiss Brain Institute (S.P.D., M.D.H.)University of Calgary, Canada."
          }
        ],
        "LastName": "Hill",
        "ForeName": "Michael D",
        "Initials": "MD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Physical Medicine and Rehabilitation (A.K., J.Y.), University of British Columbia, Vancouver, Canada."
          }
        ],
        "LastName": "Krassioukov",
        "ForeName": "Andrei",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Physical Therapy (T.D.K., T.L.-A., A.S., J.J.E.), University of British Columbia, Vancouver, Canada."
          }
        ],
        "LastName": "Liu-Ambrose",
        "ForeName": "Teresa",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Physical Medicine and Rehabilitation, University of Manitoba (S.P.)."
          }
        ],
        "LastName": "Pooyania",
        "ForeName": "Sepideh",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Physiology & Pharmacology (M.J.P.) University of Calgary, Canada."
          }
        ],
        "LastName": "Poulin",
        "ForeName": "Marc J",
        "Initials": "MJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Physical Therapy (T.D.K., T.L.-A., A.S., J.J.E.), University of British Columbia, Vancouver, Canada."
          }
        ],
        "LastName": "Schneeberg",
        "ForeName": "Amy",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Physical Medicine and Rehabilitation (A.K., J.Y.), University of British Columbia, Vancouver, Canada."
          }
        ],
        "LastName": "Yao",
        "ForeName": "Jennifer",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Physical Therapy (T.D.K., T.L.-A., A.S., J.J.E.), University of British Columbia, Vancouver, Canada."
          }
        ],
        "LastName": "Eng",
        "ForeName": "Janice J",
        "Initials": "JJ"
      }
    ],
    "DataBankList": [
      {
        "DataBankName": "ClinicalTrials.gov",
        "AccessionNumberList": [
          "NCT01915368"
        ]
      }
    ],
    "GrantList": [
      {
        "GrantID": "FDN 143340",
        "Agency": "CIHR",
        "Country": "Canada"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial, Phase III",
      "Journal Article",
      "Multicenter Study",
      "Randomized Controlled Trial",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Stroke",
    "NlmUniqueID": "0235266",
    "ISSNLinking": "0039-2499"
  },
  "CommentsCorrectionsList": [
    {
      "RefSource": "Stroke. 2020 Sep;51(9):2611-2612",
      "PMID": "32811380"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exercise"
    },
    {
      "QualifierName": [
        "adverse effects",
        "methods"
      ],
      "DescriptorName": "Exercise Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Inpatients"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Physical Endurance"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Quality of Life"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Recovery of Function"
    },
    {
      "QualifierName": [
        "adverse effects",
        "methods"
      ],
      "DescriptorName": "Stroke Rehabilitation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Walking"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Walking Speed"
    }
  ]
}